Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5276 USD | -1.62% | +5.73% | -18.83% |
25/03 | Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data | MT |
25/03 | Top Premarket Gainers | MT |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Arthur
CEO | Chief Executive Officer | 61 | 19/19/19 |
Mark Rosenblum
DFI | Director of Finance/CFO | 70 | 10/19/10 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19/19/19 |
Nadeem Q. Mirza
PRN | Corporate Officer/Principal | - | 23/20/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Hanish
BRD | Director/Board Member | 76 | 19/19/19 |
Paul Lammers
BRD | Director/Board Member | 66 | 19/19/19 |
Jonathan Lieber
BRD | Director/Board Member | 54 | 19/20/19 |
William McVicar
CHM | Chairman | 66 | 19/19/19 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19/19/19 |
Tess Burleson
BRD | Director/Board Member | 57 | 19/19/19 |
David Arthur
CEO | Chief Executive Officer | 61 | 19/19/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,776,433 | 4,486,213 ( 93.92 %) | 0 | 93.92 % |
Company contact information
Salarius Pharmaceuticals, Inc.
2450 Holcombe Boulevard Suite X
77021, Houston
+
http://salariuspharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.83% | 2.28M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+45.32% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- SLRX Stock
- Company Salarius Pharmaceuticals, Inc.